Protocol #0207-544: a phase study to evaluate the safety and pharmacokinetics of Pro-1, a liposome-encapsulated thymidine kinase gene formulation, in patients with stage IV metastatic melanoma

Hum Gene Ther. 2003 Feb 10;14(3):310-2.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents / pharmacokinetics*
  • Clinical Protocols
  • Gene Transfer Techniques*
  • Humans
  • Liposomes / pharmacokinetics*
  • Melanoma / therapy*
  • Middle Aged
  • Neoplasm Metastasis / therapy*
  • Thymidine Kinase / genetics*
  • Thymidine Kinase / pharmacokinetics

Substances

  • Antineoplastic Agents
  • Liposomes
  • Thymidine Kinase